fbpx Skip to main content
 

Search

Janssen Search

Search results

474 SEARCH RESULTS FOR

innovation

Not finding what you're looking for? Visit Janssen in your country.
PAGE 12 OF 48

Pages

Providing Patients with Prostate Cancer and Blood Cancer More Time   September is Prostate Cancer and Blood Cancer Awareness Month, and while these diseases may not seem to have much in common, in fact they share inseparable characteristics. Despite ...

Janssen Storytellers Series: Meet Brian We’re proud to share the story of Brian, one of our Janssen Immunology scientists who is dedicated to innovation for people living with and susceptible to immune diseases.  Stay tuned for more videos in the ...

Our Affiliates in Oncology Considering oncology patients at every stage of their journey We facilitate scientific interchange and collaboration among our extensive worldwide family of companies. The decentralized business model of the Johnson & ...

Folgen Sie Janssen in sozialen Medien May 13, 2015 Wir wissen, dass unsere Kunden, Partner, Kollegen und andere mit einem Interesse an unserem Unternehmen auf Social-Media-Seiten aktiv sind. Wir möchten an den Gesprächen teilnehmen, so dass wir Ideen ...

Janssen Stands United with Patients on World IBD Day 2018   On May 19, we recognize World Inflammatory Bowel Disease (IBD) Day at Janssen by shedding light on the more than five million people around the world affected by Crohn’s disease and ulcerative ...

Committed to Advancing Prostate Cancer Innovation for Patients   As this year’s American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) is upon us, I’ve been reflecting on the tremendous progress that has been made in the ...

Recognizing World Arthritis Day 2017   For more than three decades, Janssen Immunology has been focused on innovating for patients, because we understand the impact rheumatic diseases have on individuals, and their families, friends and loved ones. The ...

Prostate Cancer Janssen has built a legacy of innovation in the treatment of prostate cancer, the second most common cancer in men worldwide. We have developed a novel agent for patients with metastatic castration-resistant prostate cancer (mCRPC) and, ...

Welcome, we're glad you're here! Our mission is to redefine treatments for immune diseases by delivering transformational and accessible therapies and regimens to patients. To get there, we need to push the boundaries of science and creativity – ...

What a Whole Lot of Sweeping and a Little Bit of Vulnerability Taught Me about DEI   Racial and social justice are not just buzzwords, they are crucial elements of public health. As Head of Diversity, Equity, and Inclusion (DE&I), Pharmaceuticals, R ...

474 SEARCH RESULTS FOR

innovation

Not finding what you're looking for? Visit Janssen in your country.
PAGE 12 OF 48

Pages